Cerus Corporation
Status: Publicly traded
Direct answer
Cerus Corporation is publicly traded on NASDAQ under the ticker CERS.
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT systems specifically engineered to deactivate pathogens in donated...
Can you invest in Cerus Corporation?
Yes. Cerus Corporation is publicly traded on NASDAQ under the ticker CERS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cerus Corporation
Detailed equity research is provided by MarketSnap.